WallStreetZenWallStreetZen

NYSE: HIMS
Hims & Hers Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HIMS

Based on 10 analysts offering 12 month price targets for Hims & Hers Health Inc

Min Forecast
$26.00-53.14%
Avg Forecast
$40.60-26.82%
Max Forecast
$68.00+22.57%

Should I buy or sell HIMS stock?

Based on 10 analysts offering ratings for Hims & Hers Health Inc.

Hold
Strong Buy
2 analysts 20%
Buy
1 analysts 10%
Hold
5 analysts 50%
Sell
1 analysts 10%
Strong Sell
1 analysts 10%

Be the first to know when Wall Street analysts revise their HIMS stock forecasts and price targets.

HIMS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-11Find Out Why
lockedlocked$00.00+00.00%2025-06-04
lockedlocked$00.00+00.00%2025-05-06Find Out Why
lockedlocked$00.00+00.00%2025-05-06Find Out Why
lockedlocked$00.00+00.00%2025-04-29
TD Cowen
Top 32%
69
HoldDowngrades$30.00-45.93%2025-04-29
Truist Securities
Bottom 1%
1
HoldMaintains$33.00-40.52%2025-04-10
Leerink Partners
Top 12%
89
HoldMaintains$40.00-27.90%2025-02-25Find out why
Canaccord Genuity
Top 11%
90
Strong BuyMaintains$68.00+22.57%2025-02-19Find out why
BTIG
Bottom 12%
12
Strong BuyInitiates Coverage On$35.00-36.91%2025-01-07

1 of 1

Forecast return on equity

Is HIMS forecast to generate an efficient return?

Company
104.32%
Industry
219.63%
Market
90.47%
HIMS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HIMS forecast to generate an efficient return on assets?

Company
64.26%
Industry
15.48%
HIMS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HIMS earnings per share forecast

What is HIMS's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$0.73-1.74%
Avg 2 year Forecast
$1.04+40.11%
Avg 3 year Forecast
$1.47+98.81%
HIMS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HIMS revenue forecast

What is HIMS's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$2.3B+31.14%
Avg 2 year Forecast
$2.9B+60.82%
Avg 3 year Forecast
$3.5B+93.42%
HIMS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HIMS earnings growth forecast

How is HIMS forecast to perform vs Household & Personal Products companies and vs the US market?

Company
24.92%
Industry
7.53%
Market
15.33%
HIMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HIMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HIMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HIMS revenue growth forecast

How is HIMS forecast to perform vs Household & Personal Products companies and vs the US market?

Company
24.46%
Industry
2.75%
Market
9.68%
HIMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HIMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HIMS vs Household & Personal Product Stocks

TickerPricePrice TargetUp/downsideConsensus
HIMS$55.48$40.60-26.82%Hold
CLX$123.07$148.50+20.66%Hold
ELF$125.26$113.14-9.67%Strong Buy
IPAR$136.06$162.00+19.07%Strong Buy
COTY$4.73$7.08+49.62%Hold
View Top Household & Personal Product Stocks

Hims & Hers Health Stock Forecast FAQ

Is Hims & Hers Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NYSE: HIMS) stock is to Hold HIMS stock.

Out of 10 analysts, 2 (20%) are recommending HIMS as a Strong Buy, 1 (10%) are recommending HIMS as a Buy, 5 (50%) are recommending HIMS as a Hold, 1 (10%) are recommending HIMS as a Sell, and 1 (10%) are recommending HIMS as a Strong Sell.

If you're new to stock investing, here's how to buy Hims & Hers Health stock.

What is HIMS's earnings growth forecast for 2025-2027?

(NYSE: HIMS) Hims & Hers Health's forecast annual earnings growth rate of 24.92% is forecast to beat the US Household & Personal Products industry's average forecast earnings growth rate of 7.53%, and it is also forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Hims & Hers Health's earnings in 2025 is $164,395,000.On average, 6 Wall Street analysts forecast HIMS's earnings for 2025 to be $162,747,900, with the lowest HIMS earnings forecast at $138,775,544, and the highest HIMS earnings forecast at $217,743,305. On average, 6 Wall Street analysts forecast HIMS's earnings for 2026 to be $232,068,522, with the lowest HIMS earnings forecast at $176,826,902, and the highest HIMS earnings forecast at $329,211,403.

In 2027, HIMS is forecast to generate $329,300,935 in earnings, with the lowest earnings forecast at $268,597,826 and the highest earnings forecast at $408,402,995.

What is HIMS's revenue growth forecast for 2025-2027?

(NYSE: HIMS) Hims & Hers Health's forecast annual revenue growth rate of 24.46% is forecast to beat the US Household & Personal Products industry's average forecast revenue growth rate of 2.75%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Hims & Hers Health's revenue in 2025 is $1,784,353,000.On average, 7 Wall Street analysts forecast HIMS's revenue for 2025 to be $523,770,909,605, with the lowest HIMS revenue forecast at $515,237,780,492, and the highest HIMS revenue forecast at $535,427,383,776. On average, 7 Wall Street analysts forecast HIMS's revenue for 2026 to be $642,304,249,553, with the lowest HIMS revenue forecast at $603,763,147,443, and the highest HIMS revenue forecast at $676,038,345,897.

In 2027, HIMS is forecast to generate $772,501,897,775 in revenue, with the lowest revenue forecast at $678,097,595,899 and the highest revenue forecast at $881,672,365,158.

What is HIMS's forecast return on assets (ROA) for 2025-2028?

(NYSE: HIMS) forecast ROA is 64.26%, which is higher than the forecast US Household & Personal Products industry average of 15.48%.

What is HIMS's Price Target?

According to 10 Wall Street analysts that have issued a 1 year HIMS price target, the average HIMS price target is $40.60, with the highest HIMS stock price forecast at $68.00 and the lowest HIMS stock price forecast at $26.00.

On average, Wall Street analysts predict that Hims & Hers Health's share price could fall to $40.60 by Jun 11, 2026. The average Hims & Hers Health stock price prediction forecasts a potential downside of 26.82% from the current HIMS share price of $55.48.

What is HIMS's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: HIMS) Hims & Hers Health's current Earnings Per Share (EPS) is $0.74. On average, analysts forecast that HIMS's EPS will be $0.73 for 2025, with the lowest EPS forecast at $0.62, and the highest EPS forecast at $0.97. On average, analysts forecast that HIMS's EPS will be $1.04 for 2026, with the lowest EPS forecast at $0.79, and the highest EPS forecast at $1.47. In 2027, HIMS's EPS is forecast to hit $1.47 (min: $1.20, max: $1.82).

What is HIMS's forecast return on equity (ROE) for 2025-2028?

(NYSE: HIMS) forecast ROE is 104.32%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.